Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years

NCT02215863 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1195

Enrollment

OTHER

Sponsor class

Conditions

Influenza
Streptococcus Pneumoniae

Interventions

BIOLOGICAL: Fluad and Prevenar13
BIOLOGICAL: Fluad
BIOLOGICAL: Prevenar13

Sponsor

Korea University Guro Hospital

Collaborators

[object Object]